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Here we demonstrate two mEos4 variants whose fluorescence and photoconversion better survive OsO 4 fixation. These variants allowed super-resolution PALM visualization of organelles and fused proteins in the context of well-preserved ultrastructure in both transmission EM (TEM) and scanning EM (SEM). Photophysical properties of the mEos4 probes in 0.5-1% OsO 4 fixed tissue were comparable to those of mEos2 in typical PALM preparations. Additionally, the probes show greater thermodynamic stability than mEos2, and one is more monomeric.
Previously, EosFP was demonstrated to function in PALM imaging in cryo-sections with subsequent TEM imaging 4 . For embedding, Epon epoxy resin is preferred, given its ultrastructure preservation and sectioning properties. However, Epon is water-incompatible, seemingly precluding FP fluorescence. In contrast, the hydrophilic resin glycol methacrylate (GMA) preserves EosFP fluorescence, allowing correlative PALM and EM in resin-embedded samples, albeit requiring <0.001% OsO 4 (ref. 11) . We adopted this GMA-embedding protocol with modifications (higher GMA concentration), both for general use and for OsO 4 compatibility.
To optimize primary fixation conditions, we transfected Chinese hamster ovary (CHO) cells with constructs expressing mEos2-paxillin and subsequently treated the cells with a number of fixatives, alone and in combination. Of the treatments tested, 4% paraformaldehyde (PFA) with 0.2% glutaraldehyde best balanced mEos2 fluorescence preservation, paxillin distribution, low autofluorescence 15 and cellular structure preservation (Supplementary Fig. 1 ). We also compared TEM ultrastructure preservation of untransfected CHO cells fixed in these conditions and embedded in GMA or Epon (Supplementary Fig. 2 ).
To identify fixation-tolerant EosFP variants, we produced mutants of mEos2 and tested the purified proteins in increasing OsO 4 concentrations (Fig. 1a,b and Supplementary Table 1) . Variants designated mEos4a and mEos4b survived OsO 4 incubation much better than did mEos2, mEos3.1 and mEos3.2 (ref. 9) , both in the green (Fig. 1a) and photoconverted red (Fig. 1b) states. Subsequently, we transfected CHO cells with mitochondrially targeted mEos2, mEos4a or mEos4b. Transfected cells were post-fixed with 0% or 1% OsO 4 and embedded in GMA for light and electron microscopy ( Fig. 1c,d ). mEos2 fluorescence showed no survival with 1% OsO 4 , whereas both mEos4 variants showed strong fluorescence localized to mitochondria (Fig. 1c) , with good preservation of EM ultrastructure (Fig. 1d) . OsO 4 resistance in the purified protein assay was lower than in a cellular context, fixation-resistant photoactivatable fluorescent proteins for cLem fluorescent proteins facilitate a variety of imaging paradigms in live and fixed samples. however, they lose their fluorescence after heavy fixation, hindering applications such as correlative light and electron microscopy (cLem). here we report engineered variants of the photoconvertible eos fluorescent protein that fluoresce and photoconvert normally in heavily fixed (0.5-1% oso 4 ), plastic resin-embedded samples, enabling correlative super-resolution fluorescence imaging and high-quality electron microscopy.
Fluorescent proteins (FPs) have revolutionized microscopy 1 . Some FPs are photoactivatable 2 , meaning that they switch between dark and bright states or convert between two differently colored states. Photoactivatable FPs have enabled the super-resolution 3 imaging modality photoactivation localization microscopy (PALM) 4, 5 . Many PALM experiments employ the coral-derived green-to-red photoconvertible fluorescent protein EosFP 6 or its derivatives monomeric EosFP (mEos) 7 10 and mildly fixed samples.
CLEM combines ultrastructural information from electron microscopy (EM) and localization data from fluorescence, which can be targeted to specific fusion proteins or organelles. However, FPs are destroyed by exposure to the fixative osmium tetroxide (OsO 4 ) at concentrations typically used for EM (0.5-1%). In addition to decreasing FP fluorescence, OsO 4 affects photoconversion, even at trace levels. Thus, the use of FPs in CLEM has relied on weak chemical fixation (<0.001% OsO 4 ), which is not optimal for ultrastructure preservation 11 . Some methods preserve ultrastructure without OsO 4 , but at the expense of resin compatibility, precluding serial-sectioning of large samples 12, 13 . For samples less than 500 nm thick, the combination of PALM imaging of photoactivatable GFP likely because OsO 4 has many targets in the latter but only Eos in the former. In addition to improved OsO 4 resistance, the new variants exhibited better thermodynamic stability, monomericity and performance in protein fusions than mEos2 ( Supplementary  Figs. 3-5) . Purified-protein photophysics were identical to those of mEos2 (Supplementary Table 2) . A sequence alignment of the variants and related FPs is shown in Supplementary Figure 6 . In living cells, both mEos4 variants showed good performance in tracking microscopy, and in PALM they yielded similar numbers of total emitted photons as mEos2 (Supplementary Fig. 7 ).
For CLEM, we used two techniques: a consecutive-section approach, in which adjacent sections were imaged by PALM and EM (Fig. 2) , and a same-section approach, in which individual sections were imaged first by PALM and then by EM (Fig. 3) . First, we expressed mEos4b fused to the nuclear laminar protein lamin A (lamin A-mEos4b) in 3T3 (mouse embryonic fibroblast) cells. After this, cells were primary-fixed as before, secondary-fixed with 1% OsO 4 and uranyl acetate (UA), dehydrated and embedded in GMA, and sectioned and transferred to EM grids and glass coverslips (Fig. 2a) . TEM produced high-contrast images with well-preserved membranes, mitochondria (cristae clearly resolved) and other structures. PALM yielded large fluorescence counts, with low background and clear labeling of the nuclear membrane (Fig. 2b) . The two images were registered by hand, with fluorescence aligning to the nuclear envelope bilayer.
As an illustration of the same-section approach, we first repeated the experiment shown in Figure 2 with primary fixation followed by high-pressure freezing and freeze substitution (HPF-FS) with 0.5% OsO 4 , GMA embedding, PALM, and subsequent post-staining and TEM (Fig. 3a) . The quality of PALM and EM images from the same-section (Fig. 3b) and consecutive-section (Fig. 2b) approaches was similar. An advantage of the same-section method is that gold nanoparticles allow precise image registration with low, quantifiable error (typically ~5 nm), thus enabling quantitative correlative localization analysis of PALM and EM 16 . Subsequently, we demonstrated generality of the same-section method by imaging mitochondrially targeted mEos4a in PALM and both TEM and SEM (Fig. 3c) . As before, ultrastructure preservation allowed clear resolution of membrane bilayers, mitochondrial cristae, chromatin and other organelles. Super-resolution localization of the mEos4a probe showed it in the intracristal matrix, as expected from fusion to a matrix-targeting tag. Localization precisions of mitochondrial mEos4a and lamin A-mEos4b (Fig. 3) in 0.5% OsO 4 were similar to that of mEos2 without OsO 4 ( Supplementary Fig. 8 ). Given the performance of the mEos4 variants in GMA, we subsequently tested them in Epon, but they did not survive (Supplementary Fig. 9 ). We also tested the resistance of the photoconverted red species to OsO 4 ; it did not survive 1% OsO 4 (Supplementary Fig. 10 ).
Several techniques, each with its own strengths and weaknesses, enable the fine localization of target proteins, organelles or cells. These methods include the endogenous expression of a contrast agent, the exogenous addition of contrast through antibodies and other affinity reagents, and the direct injection of cells with 17 or APEX (enhanced ascorbate peroxidase) 18 allows for the creation of EM-dense deposits following incubation with substrates such as diaminobenzidine. However, substrate addition is difficult and uneven and can lead to poor staining. Also, diffusion of the polymerized diaminobenzidine limits utility of these enzymes for protein localization. The designed oxidase miniSOG (mini singlet oxygen generator) 19 is additionally fluorescent, facilitating CLEM, although not with optical super-resolution.
The mEos4 labels are compatible with 0.5-1% OsO 4 -fixed plasticized sections and enable large-volume, serial-section samples, under both diffraction-limited and super-resolution imaging. Of the techniques reviewed above, only those that work in plastic resin can be scaled up to the samples of greatest interest to neuroscience, i.e., whole brains or large portions thereof. Such use could assist large-scale connectomics projects, which suffer from the inability to track cellular identity solely in EM. Adding a fluorescent marker to a sparse set of neurons would make neurite tracing more resistant to experimental difficulties such as folds, slice loss and human or algorithm error. Fluorescence preservation in large tissue blocks would also facilitate selection of small target regions for EM data collection. Developing Eos (or other FP) variants that survive Epon embedding will decrease the sectioning loss rate and somewhat improve ultrastructure preservation over that with GMA; both factors will assist in tracing thin axons and dendrites over many hundreds or even thousands of serial sections. Plasticization also increases electron dose tolerance as well as compatibility of preserved samples with tomography and heavy-metal staining 20 .
Which of the two sample-preparation methods and two probes shown here should experimenters use? The consecutive-section technique is easier and minimizes sample handling, whereas the same-section technique allows for more precise, quantitative registration of light and EM images. mEos4b is an effectively pure monomer and should be considered first when target proteins are recalcitrant to fusion. On the other hand, mEos4a may be more appropriate for 'filling' applications, in which whole cells or organelles are marked with fluorescence.
The resistance of the mEos4 probes to damage from rigorous fixation validates the design goals of improved thermodynamic stability and reduced surface side-chain reactivity. For the green state, this resistance was sufficient to survive 1% OsO 4 fixation and resin embedding; for the red state, the degree of stabilization was insufficient. Further rounds of engineering may improve red-state resistance and/or Epon compatibility. Finally, it is possible that other FP scaffolds and enzymes (for example, horseradish peroxidase) could be optimized by this protein-engineering paradigm. methods Methods and any associated references are available in the online version of the paper.
Accession codes. GenBank/EMBL/DDBJ: KJ126789 (mEos4a) and KJ126790 (mEos4b). Plasmids encoding mEos4a and mEos4b as N-and C-terminal fusion proteins, as well as for bacterial expression, are available from Addgene (51072, 51073, 54810, 54811, 54812, 54813, 54814). Other fusion proteins are available upon request. onLine methods Note, Supplementary Methods, pertaining to data shown in the supplementary materials, are available online. Additional material is available on the Looger lab website (http://janelia.org/lab/ looger-lab/). Navigate to "Publications," select this paper, and a link to the additional material will show up. Readers are directed to the additional materials by "see website" below.
Rational design of mEos4 variants. mEos2 was systematically mutated, primarily at surface positions, to simultaneously improve monomericity and fixation resistance by reducing surface reactivity and improving thermodynamic stability. First, a valine was added in the second position to improve Kozak translational efficiency 21 . Thermodynamic stability was greatly increased by addition of the mutations Phe34Tyr and Ser39Thr, and to a lesser extent by Ala69Val and Ile102Tyr (Supplementary Fig. 3 ). Both Phe34Tyr and Ser39Thr increase β-strand preference 22 ; the Phe34Tyr mutation also increases hydrophilic character on the protein surface. Mutations to promote monomericity were designed to obstruct dimerization interfaces in the EosFP/mEos2 crystal structures 9, 23 or taken directly from mEos3.1/3.2 (ref. 9). The mEos3.2 mutations Ile102Asn/His158Glu/Tyr189Ala 9 improve monomeric performance ( Supplementary Fig. 4 ).
To a lesser extent, the Ile102Tyr mutation in mEos4a increases its monomericity relative to mEos2 (Supplementary Fig. 4) . Monomericity of all mutants tested in this study is shown on the Looger lab website. Fixation resistance was introduced by mutating reactive surface residues (Lys, His, Cys, Met) to preserve charge and size while reducing nucleophilicity (typically Lys to Arg; His to Gln or Asn; Cys to Ala; Met to Leu). Lys9Arg and Cys195Ala each enhance fixation resistance, and the effects are additive (Fig. 1a,b Figure 6 . The mutations were combined into two mEos4 variants: mEos4a = mEos2+Lys9Arg/Phe34Tyr/Ser39Thr/Ala69Val/Ile102Tyr/ Cys195Ala and mEos4b = mEos2+Lys9Arg/Phe34Tyr/Ser39Thr/ Ala69Val/Ile102Asn/His158Glu/Tyr189Ala/Cys195Ala. Both variants show high thermodynamic stability ( Supplementary  Fig. 3) ; improved monomericity relative to mEos2 (mEos4b being completely monomeric; Supplementary Fig. 4) ; bright and photostable green and red states, with good photoconversion between the two (Supplementary Table 2 ; see website); and resistance to fixatives (Fig. 1a,b and Supplementary Table 1) . The probes were bright under both one-and two-photon excitation (see website). pH titrations of the mEos4 variants are similar to mEos2 (see website). Mutant Eos variants were produced in Escherichia coli with a 6-histidine affinity tag and purified according to standard protocols 8 . Protein characterization consisted of thermal denaturation ( Supplementary Fig. 3) ; fluorescence polarization, gel filtration, and analytical ultracentrifugation measurements to determine monomeric character ( Supplementary  Fig. 4) ; cell-free assay of the incubation with OsO 4 in 96-well plates (Fig. 1a,b and Supplementary Table 1) ; and one-and two-photon spectroscopy (see website).
Purified protein testing. Mutants of mEos2 in the pRSETa vector (Invitrogen) were made by QuikChange (Agilent) or Kunkel 25 mutagenesis in E. coli XL1-Blue (Agilent). Point mutants were created first, with subsequent combination of beneficial mutations. Proteins were produced at 37 °C in E. coli BL21(DE3) grown in Studier auto-induction medium 26 supplemented with 60 µg/ml ampicillin. Bacterial pellets were then resuspended in 30 ml "native lysis" buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 10 mM imidazole, pH 8.0, adjusted with NaOH; protease inhibitors). Cell pellets were mechanically disrupted with an EmulsiFlex-C5 highpressure homogenizer (Avestin). The supernatant was incubated overnight with 50% Ni-NTA resin (Bio-Rad) by rotating slowly on a rotary shaker, at 4 °C. The pre-equilibrated solution was carefully loaded onto an empty, clean 20 ml column (1.5 × 12 cm polypropylene; Bio-Rad), and purified by gravity-flow chromatography (batch purification). The flow-through was collected by washing four times with 20 ml "native wash" buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 20 mM imidazole, pH 8.0, adjusted with NaOH) and kept for SDS-PAGE analysis, followed by 5-6 2 ml fractions collected in "elution" buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 250 mM imidazole, pH 8.0, adjusted with NaOH) and kept for SDS-PAGE analysis.
Cell-free OsO 4 resistance assay. Pure proteins were dialyzed into 50 mM sodium phosphate buffer, pH 7.4, and normalized by concentration by A 280 . A 4% (wt/vol) OsO 4 solution (Electron Microscopy Sciences) was diluted to a final concentration of 1% and serial diluted in 96-well black fluorescence plates with clear bottoms (Greiner). Pure protein was added to the serial dilution to a final concentration of 1 µM and immediately sealed from the top with a clear seal (Bio-Rad). After 10-min incubation with OsO 4 , fluorescence in both the green (Ex. 480 nm/Em. 515 nm; bandwidth 5 nm/5 nm) and red (Ex. 550 nm/Em. 580 nm; bandwidth 5 nm/5 nm) channels was measured from the bottom before and after conversion. All measurements were with identical fluorometer settings. Photoconversion was performed for half an hour on a Spectro-linker XL-1500 UV cross-linker, equipped with five 8-W 365 nm tubes, each with a power of 5 mW/cm 2 (Spectronics). Red signal after conversion was subtracted from red signal before conversion. Fluorescence was normalized to that in 0% OsO 4 . For initial screening, only the green fluorescence channel was recorded, and OsO 4 concentration was held at 0%, 0.05% or 0.1%. The final variants and mEos2 were tested in a separate assay with more sample points, from 0-1% OsO 4 .
Cell culture. All cell lines used in these experiments have been verified to be free from contaminating mycoplasma, viruses and other cells.
Performance in protein fusions. To assess the performance of mEos4a and mEos4b in live-cell imaging applications, a number of fusion proteins were constructed to the C and N termini of the mEos4 probes. All fusion proteins localized as expected, for example α-tubulin, CytERM and connexin-43 (Supplementary Fig. 5 ). Protein fusions were successful across all cellular compartments, including the cytoskeleton, nucleus, mitochondrion, endoplasmic reticulum, etc. (see website). Neither fluorescent protein affected the mitotic cycle when fused to histone 2B (Supplementary  Fig. 7; see website) . All Eos variants, fused to CytERM, were also tested in an organized smooth endoplasmic reticulum (OSER) assay, which is a sensitive method for detecting effective protein monomericity in fusions 27 . The new versions performed better than tdEos, mEos2 and dEos (Supplementary Fig. 5; see website) . A number of fusion proteins were subsequently tested in PALM and photoconversion-tracking microscopy ( Supplementary  Fig. 7; see website) .
Construction of mammalian expression plasmids and cell culture. The mEos4 (mEos4a, mEos4b) fusion proteins were constructed using C1 and N1 (Clontech-style) cloning vectors. Using PCR, the mEos4a and mEos4b cDNAs were amplified with a 5′ primer encoding an AgeI site and a 3′ primer containing either a BspEI (C1) or NotI (N1) site for creating the C-terminal and N-terminal (with respect to the FP) cloning vectors. The PCR products were gel purified, digested, and ligated to identically treated EGFP-C1 and EGFP-N1 cloning vectors.
To construct the mEos4a or mEos4b fusions to the C terminus of the fluorescent protein (number of linker amino acids in parentheses), the subsequent digests were performed: human lamin A (18), NheI and BglII (cDNA source: D. Gilbert, Florida State University; NM_170707.2); human α-tubulin (18), NheI and BglII (cDNA source: Clontech; NM_006082); human H2B (6), BglII and NheI (histones, cDNA source: G. Patterson, NIH; NM_021058.3). To prepare the N-terminal fusions to mEos4a, the following digests were performed: rat connexin-43 (7), BamHI and NotI (cDNA source: M. Falk, Lehigh University; NM_001004099.1); cytERM (17), AgeI and NotI (rabbit cytochrome p450, E. Snapp, Albert Einstein College of Medicine; XM_002718526.1). For the mitochondrial-targeted proteins, the N-terminal sequence ATGTCCGTCCTGACGCCGCTGCTGC TGCGGGGCTTGACAGGCTCGGCCCGGCGGCTCCCAGTG CCGCGCGCCAAGATCCATTCGTTG (MSVLTPLLLRGLTGS ARRLPVPRAKIHSL), from human cytochrome c oxidase subunit 8A, followed by a linker GGGGATCCACCGGTCGCCACC (GDPPVAT) was cloned before mEos, using 5′ BamHI/3′ NotI. Following digestion with the appropriate restriction enzymes and gel purification, the plasmids were ligated together with the similarly digested and gel-purified mEos4a or mEos4b cloning vector and purified using a Plasmid Maxiprep kit (Qiagen).
For cell culture for EM experiments, we largely followed the protocol of Brown et al. 28 . Briefly, 35-mm glass-bottom dishes (MatTek corporation) were precoated with 5-10 µg/ml fibronectin (Millipore) in 1× PBS (Gibco) before cells were plated. Chinese hamster ovary cells (CHO-K1, ATCC), adherent fibroblastoid cells (ATCCR CCl-61, cryopreserved) or 3T3 mouse fibroblast cells (Life Technologies) were used (specified in each experiment). CHO cells were maintained in complete basal growth medium: Dulbecco's modified Eagle's medium (DMEM)/F12 (Gibco) + 10% FBS (Gibco). 3T3 cells were maintained in DMEM, 10% (wt/vol) normal calf serum, 1 mM sodium pyruvate, 4 mM l-glutamine, 4.5 g/ml glucose, and 1.5 g/ml sodium bicarbonate. ~4 × 10 5 live CHO cells, and ~8 × 10 5 live 3T3 cells, were used per imaging well. For analysis of fixation conditions, untransfected cells were examined to measure background fluorescence. Transfected cells were measured to ensure retention of mEos fluorescence. Cells were transfected with 1 µg DNA per well using an Amaxa SF Cell Line 96-well electroporator with the Nucleofector kit (Lonza).
After transfection, cells were moved to a 37 °C incubator. Cells were imaged 24 h after transfection.
Primary fixation for light and electron microscopy. We first established a cellular assay in which fixative conditions could be tested for structure preservation, effect on EosFP fluorescence, and production of interfering background fluorescence. CHO cells were transfected with constructs expressing mEos2-paxillin and subsequently treated with a number of primary fixatives, alone and in combination (Supplementary Fig. 1 ). Cells were imaged and quantified for brightness of mEos2 in both the green and red channels. Cells with no FP were treated identically to assess background fluorescence. In parallel, fixatives were evaluated for overall cellular structure preservation. Cell culture medium was DMEM, with 4.5 g/l glucose and 110 mg/l sodium pyruvate added, with no phenol red added. For 3T3 cells (but not for others), 200 mM glutamine was also added. Most fixative treatments were discarded for high background fluorescence in green (for example, Hand and Hassel), red (for example, DTSSP) or both (for example, 2.5% glut, ETA) channels; destruction of green Eos fluorescence (for example, 2.5% glut); for mislocalized Eos (for example, DMS, DTSSP), or for unacceptable cellular structure preservation (for example, Zn, BS3). Of the treatments tested, 4% PFA with 0.2% glutaraldehyde best balanced Eos fluorescence preservation, low autofluorescence and structure preservation ( Supplementary  Fig. 1 ). Under these primary fixation conditions, mEos2 fluorescence decreased by ~30% in the green channel and ~40% in the red, with good distribution pattern, judged from fluorescence images. (See Additional Methods on website for detailed description of fixatives tested and image analysis methods.) Subsequently, untransfected cells (i.e., no mEos) were prepared according to several EM protocols 29 and checked for fine ultrastructure preservation (Supplementary Fig. 2 ). Conventional EM preparation (2% PFA, 2.5% glut, 1% OsO 4 , Epon 12 resin) provided excellent ultrastructure (Supplementary Fig. 2c ). We carried out systematic testing of EM conditions and were able to achieve good structural preservation with both conventional EM chemical fixation (CCF; Supplementary Fig. 2a-c) and high-pressure freezing/freeze substitution (HPF-FS; Supplementary Fig. 2k-n) . Increasing OsO 4 concentration improved structure ( Supplementary  Fig. 2f-j,k-m) . At 1% OsO 4 , ultrastructure in glycol methacrylate (GMA) resin (Supplementary Fig. 2k,m) was excellentequivalent to that in Epon resin (Supplementary Fig. 2b,n) . In low OsO 4 , neither resin showed particularly good ultrastructure. The use of free-aldehyde quenchers such as borohydride (NaBH 4 ) and cyanoborohydride (NaCNBH 3 ) 30 after chemical fixation (but before resin infiltration, i.e., pre-embedding) resulted in cellular damage, primarily through bubble formation ( Supplementary  Fig. 2d,e) . However, when used in an optimized post-embedding procedure on resin section, they improved fluorescence imaging without adversely affecting structure (Figs. 2 and 3 ).
Fixation and embedding for CLEM. Cultured cells (3T3, CHO, HeLa) transfected with mEos4 variants were fixed after 24-48 h of expression with 4% PFA and 0.2% glutaraldehyde in 100 mM phosphate buffer, pH 7.2 (PB) on ice for 1 h. After washing 3× for 3 min (3 × 3 min) on ice, cells were scraped off and pelleted. The cell pellets were then processed for embedding in GMA in two approaches: (i) CCF with progressive lowering temperature (PLT) and (ii) HPF-FS.
For CCF, the cell pellets were resuspended in 1% agar and repelleted. After the agar solidified on ice, the pellet was cut into small pieces and post-fixed with OsO 4 and stained en bloc with 1% UA. The cell pellets were dehydrated with increasing concentrations of ethanol (EtOH) up to 95% and then subjected to further dehydration and resin infiltration and embedding at −20 °C. The GMA resin (low-acid GMA kit from SPI Supplies) was made up of GMA, n-butyl methacrylate (BMA) and benzoyl peroxide (BP), with no water. For a 20 ml stock solution (100%), 14 ml of GMA, 6 ml of BMA and 120 mg of BP were mixed in a glass vial. The water-free GMA is a modification of Watanabe et al. 11 method that better enables fluorescence detection and improves TEM morphology. After dehydration in 95% EtOH for 1 h at −20 °C, the pellets were sequentially infiltrated with 30% and 70% GMA (GMA stock solution diluted in 95% EtOH), each for 12 h. Further infiltration was carried out with 100% water-free GMA overnight followed by two more exchanges with 100% water-free GMA the following day. The pellets were embedded in precooled 100% water-free GMA with N,N-dimethyl-p-toluidine (1.5 µl/ml GMA) in flat-bottom embedding capsules for 2 d. At the end of embedding, temperature was brought up from −20 °C to room temperature in 4 h.
For HPF-FS, the cell pellets were washed and resuspended in 20% BSA in PB. A small volume of the suspension (0.7 µl) was transferred to the 100-µm-deep well of a 0.1/0.2 mm specimen carrier (Type A, TechnoTrade) and capped by the flat side of a Type B specimen carrier. The carrier assembly was high-pressure frozen with an HPF Compact 01 high-pressure-freezing machine (TechnoTrade). The frozen carrier assembly was forced open in liquid nitrogen, and the cells were freeze substituted in acetone with 0.1% uranyl acetate and OsO 4 at the specified concentration in a Leica EM AFS2 freeze substitution unit at −90 °C for 40 h. After the temperature was brought up slowly to −20 °C, cells were rinsed with 95% EtOH six times over a period of 8 h, followed by sequential infiltration with 30% and 70% GMA in 95% EtOH for 12 h each. Further infiltration and embedding was performed as described for the CCF approach. The sample side of the specimen carrier faced up when embedded in the flat-bottom embedding capsule.
After temperature was returned to room temperature at the end of embedding, the sample blocks were removed from the embedding capsules. For samples embedded with the specimen carriers, the blocks were trimmed around the carriers, which were carefully removed with a pair of forceps after a brief cooling in liquid nitrogen. The exposed samples were further trimmed for ultrathin sectioning.
Some samples were processed with Epon (Eponate 12, Ted Pella) embedding as a control for structural preservation. Cells were processed as described in the CCF approach except that dehydration proceeded to pure EtOH at room temperature. After dehydration in pure EtOH for 3 × 10 min, samples were further dehydrated in propylene oxide 3 × 10 min. The samples were then infiltrated in mixtures of Epon and propylene oxide (1:1 then 2:1) for 1 h each, pure Epon for 2 h and then overnight. Final embedding was at 65 °C for 24 h. CLEM imaging. CLEM imaging was carried out using two complementary approaches: consecutive section and same section.
For the consecutive-section approach, two consecutive sections were cut with a Leica UC6 ultramicrotome, with one (60 nm) on a Synaptek slot grid custom coated with Pioloform (1% in 1,2-dichloroethane) for EM imaging, and one (500 nm) picked up on a specially prepared coverslip for PALM imaging.
In this case PALM coverslips were prepared in the following way. First, 80-nm bare Au nanospheres (Microspheres-Nanospheres part# 790120-010) were deposited onto 25 mm #1.5 coverslips (Werner Instruments). Then a thin layer of indium tin oxide (ITO) was sputtered over the sample using the Denton Explorer sputtering system (Denton Vacuum). The exact thickness of the ITO layer was not measured; instead we measured the electrical resistance between two point across the coverslip, which was ~2 kΩ. The optical loss of the ITO layer was less than 5%. For the same-section approach, a 60-nm section was picked up on a coverslip spin-coated first with 80-nm Au nanospheres (same nanoparticles as in the consecutive-section approach) and then with Pioloform.
Typical PALM data acquisition consisted of 20,000-80,000 frames. We used iXon DU-897E electron-multiplying chargecoupled device (EMCCD) cameras (Andor). Acquisition was performed in frame transfer mode; the laser excitation was constantly on during acquisition. Activation light was generated from a Cube 405-50 laser (Coherent), at 405 nm, 2-10 W/cm 2 , with activation durations of 0.5-50 ms per imaging frame. Excitation light was generated from a CL561-150-O laser (CrystaLaser), at 561 nm, ~1,000 W/cm 2 . Exposure time was 50 ms. We used an NF01-405/488/561/635 quad-notch filter (Semrock) and LP02-568RU and FF01-593/40 filters (Semrock) as emission filters.
For the same-section approach, after PALM imaging, an area on the coverslip with the imaged section at the center was scored with a diamond knife without breaking the glass. The Pioloform film was lifted by treatment with 1.2% hydrofluoric acid and floated on water in a glass Petri dish. An uncoated Synaptek slot grid was placed on the film, capturing the section in the center of the open slot. The grid was picked up by lifting the floating film with a piece of Parafilm. After drying, the grid was removed from the Parafilm and contrast stained with 3% UA and 1% Sato's triple lead. The grid was examined using an FEI Tecnai 20 TEM operated at 80 kV. Cells imaged with PALM were located with positioning maps generated from the PALM imaging. Images were acquired with a Gatan Ultrascan 4k × 4k camera.
In the case of subsequent SEM imaging, the sample was then coated with 2 nm of Au/Pd alloy. The coating was performed using the Precision Etching and Coating System (Model 682 PECS; Gatan). This was followed by SEM imaging, which was performed using the Ultra SEM system (Carl Zeiss) with accelerating voltage of 1.5 keV.
PALM-EM image registration was performed using Au nanoparticles. The same nanoparticles were observed under 561-nm illumination and in EM micrographs. This allowed for registration of two images using a Polywarp 1 transformation defined by the equations 16 Typical average PALM-EM registration error was ~5 nm.
Quantification of localization precision in CLEM imaging. PALM data sets were analyzed from Figure 3c (mitochondrial mEos4a) and Figure 3b (lamin A-mEos4b); both were secondarily fixed with the 0.5% OsO 4 used for HPF-FS. A lamin B1-mEos2 PALM data set was taken from figure 3 from ref. 13 . Equation (6) Reproducibility statement. Sample sizes were chosen to be sufficient to show the magnitude of effects of the different treatments.
Effects were large and qualitative and did not require statistical analysis of significance. No data were excluded.
